Cytology-based nation-wide cervical screening has led to a substantial reduction of the
incidence of cervical cancer in western countries. However, the sensitivity of cytology for the …

Cervical screening programs for detecting cancer and precancer have dramatically reduced
the incidence and mortality rates of cervical cancer since the 1960s. The efficacy of the …

In 2011, the American Cancer Society, the American Society for Colposcopy and Cervical
Pathology, and the American Society for Clinical Pathology updated screening guidelines …

High‐risk human papillomavirus (hrHPV) testing has become an integral component of
cervical cancer screening, given that persistent infection with hrHPV was recognized as a …

Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic
Evidence Review for the US Preventive Services Task Force - Abstract - Europe PMC Sign in …

Background: High-risk human papillomavirus (hrHPV) testing has higher sensitivity but
lower specificity than cytology for cervical (pre)-cancerous lesions. Therefore, triage of …

Several countries are in the process of switching to high-risk human papillomavirus (hrHPV)
testing for cervical cancer screening. Given the multitude of available tests, validated assays …

High-risk human papillomavirus (hrHPV) bearing cervical intraepithelial neoplasia (CIN) is
considered, as the real precursor lesion of cervical cancer and persistence of an hrHPV …

Cervical cancer screening in Europe: what next? - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

Traditional population‐based cervical screening programs, based on cytology, have
successfully reduced the burden of cervical cancer. Nevertheless limitations remain and …